Study questions how allergy tests should be used in canine EBP: full analysis

A new study in Frontiers in Veterinary Science suggests dogs with eosinophilic bronchopneumopathy may show more positive reactions on intradermal allergy testing than healthy dogs, but it also underscores how hard it is to translate allergy test results into clear clinical decisions. In the prospective case-control study, researchers found a significant difference in intradermal test positivity between dogs with EBP and controls, while serum allergen-specific IgE testing showed no such difference. Agreement between the two methods was minimal, reinforcing the authors’ conclusion that both tests need cautious interpretation. (frontiersin.org)

That question matters because EBP has long been viewed as a chronic inflammatory airway disease with a suspected hypersensitivity component, even though its causes are still not fully understood. Reference sources continue to describe allergens, parasites, infections, and other triggers as possible contributors, and standard workups typically focus on imaging, airway sampling, and ruling out infectious or parasitic disease. Merck Veterinary Manual notes that the benefit of allergy testing in dogs with eosinophilic bronchopneumopathy has not been documented, which makes the new paper especially relevant for clinicians deciding how much weight to give these tests in practice. (merckvetmanual.com)

The new study enrolled 21 dogs diagnosed with EBP and 22 healthy controls. Investigators performed intradermal testing with 41 allergens and an Fc-ε receptor-based serum assay covering 23 allergens. Dogs with EBP had a median of 8 positive intradermal reactions, compared with 4 in controls, a statistically significant difference. By contrast, median serum IgE positives were 11 in the EBP group and 11 in controls, with no significant difference. The overall agreement between intradermal and serum testing was minimal, with a Cohen’s kappa of 0.14. (frontiersin.org)

The findings also sit alongside earlier work that has pointed to immune reactivity in canine EBP without establishing a straightforward IgE-driven mechanism. A recently surfaced retrospective study reported increased antibody responses to Aspergillus fumigatus and house dust mite antigens in dogs with idiopathic EBP, while also noting that antigen-specific IgE concentrations were very low and did not differ between groups. Taken together, that suggests airway eosinophilic disease in dogs may involve hypersensitivity pathways that aren’t captured well by standard serum IgE testing alone. That’s an inference, but it is consistent with the pattern seen across the available studies. (pmc.ncbi.nlm.nih.gov)

There does not yet appear to be a formal press release or broad industry response tied to this paper, but the study’s message aligns with longstanding caution from veterinary allergy literature. Earlier dermatology-focused work and task force guidance have emphasized that intradermal testing is mainly useful for identifying allergens to include in immunotherapy, not for diagnosing allergic disease by itself, and that standardization and interpretation remain challenges. This new EBP paper extends that caution into respiratory medicine. (sciencedirect.com)

Why it matters: For veterinarians, the practical takeaway is restraint. A positive intradermal test in a dog with EBP may support the possibility of hypersensitivity involvement, but it shouldn’t be treated as proof of causation, especially when healthy dogs can also show positive reactions and serum IgE testing may tell a different story. In day-to-day case management, that means allergy testing may still have a role in selected patients, particularly if clinicians are considering allergen avoidance or immunotherapy, but it shouldn’t displace core diagnostics such as bronchoalveolar lavage, imaging, and exclusion of parasites or infectious disease. (frontiersin.org)

The study may be most useful as a reminder that EBP likely isn’t a single-pathway disease. Some dogs may have clinically relevant environmental hypersensitivity, while others may reach a similar eosinophilic airway phenotype through different mechanisms. For specialists and referral clinicians, that argues for individualized interpretation rather than assuming that one positive allergy panel explains the case. (frontiersin.org)

What to watch: The next step is whether future studies connect allergy test patterns with outcomes, including corticosteroid response, relapse risk, or benefit from allergen-specific immunotherapy. If that link emerges, intradermal testing could become more actionable in respiratory cases. If not, this paper may stand as further evidence that positive allergy results in dogs with EBP are best viewed as contextual data, not decision-making shortcuts. (frontiersin.org)